HUMHUMANA INC

NYSE humana.com


$ 349.10 $ -0.09 (-0.03 %)    

Tuesday, 28-May-2024 15:59:54 EDT
QQQ $ 454.82 $ 1.73 (0.38 %)
DIA $ 398.57 $ -2.04 (-0.52 %)
SPY $ 530.36 $ 0.37 (0.07 %)
TLT $ 91.26 $ -1.31 (-1.43 %)
GLD $ 225.37 $ 2.27 (1.05 %)
$ 349.21
$ 348.81
$ 349.00 x 100
$ 0.00 x 0
$ 346.30 - $ 350.59
$ 298.61 - $ 528.15
1,601,164
na
42.08B
$ 0.90
$ 21.14
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-24-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-01-2023 09-30-2023 10-Q
4 08-02-2023 06-30-2023 10-Q
5 04-26-2023 03-31-2023 10-Q
6 02-16-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 04-27-2022 03-31-2022 10-Q
10 02-17-2022 12-31-2021 10-K
11 11-03-2021 09-30-2021 10-Q
12 07-28-2021 06-30-2021 10-Q
13 04-28-2021 03-31-2021 10-Q
14 02-18-2021 12-31-2020 10-K
15 11-03-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 04-29-2020 03-31-2020 10-Q
18 02-20-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 07-31-2019 06-30-2019 10-Q
21 05-01-2019 03-31-2019 10-Q
22 02-21-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-16-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-02-2017 06-30-2017 10-Q
29 05-03-2017 03-31-2017 10-Q
30 02-17-2017 12-31-2016 10-K
31 11-04-2016 09-30-2016 10-Q
32 08-03-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-18-2016 12-31-2015 10-K
35 11-06-2015 09-30-2015 10-Q
36 07-29-2015 06-30-2015 10-Q
37 04-29-2015 03-31-2015 10-Q
38 02-18-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 07-30-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cvs-health-seeks-private-equity-partner-for-oak-street-health-expansion

CVS Health seeks a private equity partner to fund the expansion of Oak Street Health, acquired for $10.6 billion. This joint ve...

 hedge-funds-tweak-portfolios-in-q1-marvell-td-synnex-aes-get-more-love-as-focus-shifts-to-ai

Hedge funds are looking for high-return opportunities beyond the mega-cap tech giants preferring to focus on cyclical sectors a...

 b-of-a-securities-maintains-neutral-on-humana-raises-price-target-to-376

B of A Securities analyst Kevin Fischbeck maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $342 t...

 humana-announces-jim-rechtin-will-assume-the-role-of-ceo-on-july-1-2024-bruce-broussard-to-resign

Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today that Jim Rechtin will assume the...

 humana-unusual-options-activity
Humana Unusual Options Activity
05/13/2024 19:16:09

 will-earnings-cheer-continue-to-buoy-markets-apple-amazon-pfizer-coinbase-lead-flurry-of-q1-reports-this-week

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and...

 rbc-capital-maintains-outperform-on-humana-lowers-price-target-to-353

RBC Capital analyst Frank Morgan maintains Humana (NYSE:HUM) with a Outperform and lowers the price target from $415 to $353.

 ubs-maintains-neutral-on-humana-lowers-price-target-to-326

UBS analyst Kevin Caliendo maintains Humana (NYSE:HUM) with a Neutral and lowers the price target from $334 to $326.

 cantor-fitzgerald-maintains-neutral-on-humana-lowers-price-target-to-360

Cantor Fitzgerald analyst Sarah James maintains Humana (NYSE:HUM) with a Neutral and lowers the price target from $391 to $360.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION